Hull Hans

Chief Business OfficerPLIANT THERAPEUTICS, INC. (PLRX) · full profile →Form 4 · filed Aug 7, 2023
Net Selling
Open-Market Buys
$36K
Open-Market Sells
$663K
Net Open-Market Flow
-$627K
Transactions
7
5 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 4, 2023Sell(S)20K$20.01$401K195K
Aug 4, 2023Option exercise(M)9K$2.08$18K215K
Aug 3, 2023Option exercise(M)2K$2.08$4K208K
Aug 3, 2023Sell(S)13K$20.00$261K206K
Aug 3, 2023Buy(S)2K$20.00$36K206K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 4, 2023Option exercise(M)9K$031K
Aug 3, 2023Option exercise(M)2K$040K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-044892) within minutes of acceptance. Every field above traces to the original document. Verify it directly: